iBio
IBIO
#10077
Rank
S$89.38 M
Marketcap
S$1.80
Share price
-0.36%
Change (1 day)
137.31%
Change (1 year)

iBio (IBIO) - Cash on Hand

Cash on Hand as of March 2026 : S$95.78 Million

According to iBio's latest financial reports the company has S$95.78 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

iBio - Cash on Hand chart (from 2008 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-06-30S$10.9 M-43.35%
2024-06-30S$19.25 M231.02%
2023-06-30S$5.81 M-87.52%
2022-06-30S$46.59 M-64.26%
2021-06-30S$0.13 B69.78%
2020-06-30S$76.8 M1185.19%
2019-06-30S$5.97 M-72.48%
2018-06-30S$21.71 M95.05%
2017-06-30S$11.13 M-64.09%
2016-06-30S$31 M142.36%
2015-06-30S$12.79 M185.82%
2014-06-30S$4.47 M-20.1%
2013-06-30S$5.6 M-21.4%
2012-06-30S$7.12 M104.23%
2011-06-30S$3.48 M176.15%
2010-06-30S$1.26 M-15.83%
2009-06-30S$1.5 M5704.27%
2008-06-30S$0.02 M-10.49%
2007-06-30S$0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$28.23 B 29,381.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S$25.78 M-73.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$0.72 B 660.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.20 B 114.31%๐Ÿ‡บ๐Ÿ‡ธ USA